Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study.
Hillert J, Butzkueven H, Magyari M, Wergeland S, Moore N, Soilu-Hänninen M, Ziemssen T, Kuhle J, Pontieri L, Forsberg L, Aarseth JH, Zhu C, Sicignano N, Mushnikov V, Bezemer I, Sabidó M. Hillert J, et al. Among authors: sabido m. Clin Epidemiol. 2024 Oct 17;16:717-732. doi: 10.2147/CLEP.S480525. eCollection 2024. Clin Epidemiol. 2024. PMID: 39435029 Free PMC article.
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets.
Butzkueven H, Moore N, Aydemir A, Sõnajalg J, Bezemer I, Korhonen P, Sabidó M; CLARION Study Group. Butzkueven H, et al. Among authors: sabido m. Curr Med Res Opin. 2022 Jul;38(7):1167-1176. doi: 10.1080/03007995.2022.2059977. Epub 2022 Apr 28. Curr Med Res Opin. 2022. PMID: 35357268 Free article.
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden.
Hakkarainen KM, Juuti R, Burkill S, Geissbühler Y, Sabidó M, Popescu C, Suzart-Woischnik K, Hillert J, Artama M, Verkkoniemi-Ahola A, Myhr KM, Mehtälä J, Bahmanyar S, Montgomery S, Korhonen P. Hakkarainen KM, et al. Among authors: sabido m. Ther Adv Neurol Disord. 2020 Oct 7;13:1756286420951072. doi: 10.1177/1756286420951072. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33101459 Free PMC article.
Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden.
Korjagina M, Hakkarainen KM, Burkill S, Geissbühler Y, Sabidó M, Everage N, Suzart-Woischnik K, Klement R, Hillert J, Verkkoniemi-Ahola A, Bahmanyar S, Montgomery S, Korhonen P; European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group. Korjagina M, et al. Among authors: sabido m. Mult Scler Relat Disord. 2021 Feb;48:102694. doi: 10.1016/j.msard.2020.102694. Epub 2020 Dec 16. Mult Scler Relat Disord. 2021. PMID: 33429303 Free article.
71 results